10-Q Filing

ROCK CREEK PHARMACEUTICALS, INC. CIK: 776008 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-14-029610`
Period End Date	20140331
Filing Date	20140512
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	stsi-20140331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 28 Cash Flow Statement 46 Stockholders Equity 8

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.11M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.38M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.12M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Receivable from sale of licensing rights	`ReceivableFromSaleOfLicensingRights`	$18.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	213.50M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	213.50M	shares	Point-in-time
Receivable from sale of licensing rights	`ReceivableFromSaleOfLicensingRights`	$9.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	181.86M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	172.38M	shares	Point-in-time
Note receivable-short term	`NotesAndLoansReceivableNetCurrent`	$66.00K	USD	Point-in-time
Note receivable-short term	`NotesAndLoansReceivableNetCurrent`	$69.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	172.38M	shares	Point-in-time
Inventories, net	`InventoryNet`	$3.35M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	181.86M	shares	Point-in-time
Inventories, net	`InventoryNet`	$3.47M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.57M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.97M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.01M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$399.00K	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$373.00K	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$472.00K	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$454.00K	USD	Point-in-time
Note receivable long-term	`NotesAndLoansReceivableNetNoncurrent`	$500.00K	USD	Point-in-time
Note receivable long-term	`NotesAndLoansReceivableNetNoncurrent`	$517.00K	USD	Point-in-time
MSA escrow funds	`EscrowDeposit`	$482.00K	USD	Point-in-time
MSA escrow funds	`EscrowDeposit`	$482.00K	USD	Point-in-time
Assets held for sale of discontinued operations	`AssetsHeldForSaleAtCarryingValue`	$69.00K	USD	Point-in-time
Assets held for sale of discontinued operations	`AssetsHeldForSaleAtCarryingValue`	$69.00K	USD	Point-in-time
Total assets	`Assets`	$14.85M	USD	Point-in-time
Total assets	`Assets`	$10.95M	USD	Point-in-time
Accounts payable, trade	`AccountsPayableTradeCurrent`	$2.08M	USD	Point-in-time
Accounts payable, trade	`AccountsPayableTradeCurrent`	$1.73M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.09M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.81M	USD	Point-in-time
Due to stockholder	`DueToOfficersOrStockholdersCurrent`	$50.00K	USD	Point-in-time
Due to stockholder	`DueToOfficersOrStockholdersCurrent`	$50.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$4.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$29.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.97M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.97M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.87M	USD	Point-in-time
Commitments and contingencies (note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00K	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$284.15M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$271.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-264.37M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-274.19M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.98M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.97M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.95M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.85M	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueGoodsNet`	$1.12M	USD	1 Quarter
Net sales	`SalesRevenueGoodsNet`	$2.51M	USD	1 Quarter
Product cost of goods sold	`CostOfGoodsSold`	$457.00K	USD	1 Quarter
Product cost of goods sold	`CostOfGoodsSold`	$1.39M	USD	1 Quarter
Gross profit	`GrossProfit`	$666.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$1.12M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$3.15M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$825.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.95M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$715.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$10.49M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.34M	USD	1 Quarter
Operating loss from operations	`OperatingIncomeLoss`	$-8.22M	USD	1 Quarter
Operating loss from operations	`OperatingIncomeLoss`	$-9.82M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingExpense`	$2.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingExpense`	$7.00K	USD	1 Quarter
Loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-9.83M	USD	1 Quarter
Loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.22M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-8.22M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-9.83M	USD	1 Quarter
Net loss (basic and diluted) per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Net loss (basic and diluted) per common share (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	166.49M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	174.32M	shares	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`IncomeLossFromContinuingOperations`	$-8.22M	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-9.83M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$43.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$83.00K	USD	1 Quarter
Provision for inventory obsolescence	`InventoryWriteDown`	$5.00K	USD	1 Quarter
Provision for inventory obsolescence	`InventoryWriteDown`	$-1.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$5.23M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$1.00M	USD	1 Quarter
Current assets	`IncreaseDecreaseInOperatingAssets`	$552.00K	USD	1 Quarter
Current assets	`IncreaseDecreaseInOperatingAssets`	$134.00K	USD	1 Quarter
Current liabilities	`IncreaseDecreaseInOperatingLiabilities`	$-763.00K	USD	1 Quarter
Current liabilities	`IncreaseDecreaseInOperatingLiabilities`	$992.00K	USD	1 Quarter
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.01M	USD	1 Quarter
Net cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.77M	USD	1 Quarter
Proceeds from sale of licensing rights	`ProceedsFromSaleOfLicensingRights`	$9.00K	USD	1 Quarter
Proceeds from sale of licensing rights	`ProceedsFromSaleOfLicensingRights`	$8.00K	USD	1 Quarter
Net cash flows from (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$8.00K	USD	1 Quarter
Net cash flows from (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.00K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.11M	USD	1 Quarter
Proceeds from stock option and warrant exercise	`ProceedsFromStockOptionsExercised`	$4.17M	USD	1 Quarter
Proceeds from stock option and warrant exercise	`ProceedsFromStockOptionsExercised`	$30.00K	USD	1 Quarter
Payments on long-term debt	`ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities`	$-5.00K	USD	1 Quarter
Payments on long-term debt	`ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities`	-	USD	1 Quarter
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.00K	USD	1 Quarter
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.28M	USD	1 Quarter
Increase (decrease) in cash and cash equivalents from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$4.52M	USD	1 Quarter
Increase (decrease) in cash and cash equivalents from continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$-5.97M	USD	1 Quarter
Net cash flows used in operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-1.04M	USD	1 Quarter
Net cash flows used in operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-25.00K	USD	1 Quarter
Net cash flows used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows from financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows from financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash flows from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$-25.00K	USD	1 Quarter
Net cash flows from discontinued operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$-1.04M	USD	1 Quarter
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-7.01M	USD	1 Quarter
Increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.50M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$16.11M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$8.38M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.12M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$16.11M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$8.38M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.12M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.88M	USD	Point-in-time

Stockholders Equity 8 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$6.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$9.97M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.54M	USD	1 Quarter
Warrant and option exercise	`WarrantAndOptionExercise`	$4.17M	USD	1 Quarter
Stock issuance	`StockIssuedDuringPeriodValueNewIssues`	$5.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.83M	USD	1 Quarter
Balances	`StockholdersEquity`	$6.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$9.97M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.